首页> 美国卫生研究院文献>Journal of the Royal Society of Medicine >Cost-effectiveness of investigations for invasive bladder cancer.
【2h】

Cost-effectiveness of investigations for invasive bladder cancer.

机译:浸润性膀胱癌研究的成本效益。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The results of diagnostic and staging investigations in consecutive cases of invasive transitional cell carcinoma of the bladder are reviewed. Urine culture, urine cytology and intravenous urography had positive results in a high percentage of cases. As diagnostic investigations they are cost-effective but certainly do not remove the obligation to perform cystoscopy and examination under anaesthetic. Isotopic bone scan and liver scan showed metastases in 4 and one cases respectively and only when there were clinical signs of disseminated disease. Chest X-ray showed metastases in one case. These investigations are not cost-effective. Lymphangiography was positive in 12 of the 94 cases and, although expensive (pounds 70), is still a staging investigation of value in planning treatment.
机译:回顾了连续的膀胱浸润性移行细胞癌病例的诊断和分期研究结果。尿培养,尿细胞学检查和静脉输尿管造影在很多病例中均取得了积极的结果。作为诊断研究,它们具有成本效益,但当然不能免除在麻醉下进行膀胱镜检查和检查的义务。同位素骨扫描和肝扫描分别在4例和1例中显示转移,仅在有播散性疾病的临床体征时才显示。胸部X线显示转移1例。这些调查并不划算。 94例病例中有12例淋巴管造影呈阳性,尽管价格昂贵(70英镑),但仍是分阶段进行计划治疗价值的调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号